Perfromance Wealth Partners’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,850
Closed -$278K 180
2024
Q4
$278K Hold
3,850
0.01% 144
2024
Q3
$314K Hold
3,850
0.01% 140
2024
Q2
$286K Sell
3,850
-500
-11% -$37.5K 0.01% 129
2024
Q1
$339K Sell
4,350
-33
-0.8% -$2.46K 0.01% 117
2023
Q4
$313K Sell
4,383
-1,950
-31% -$136K 0.01% 130
2023
Q3
$440K Sell
6,333
-1,900
-23% -$144K 0.02% 113
2023
Q2
$649K Buy
8,233
+300
+4% +$24.5K 0.03% 97
2023
Q1
$640K Buy
7,933
+3,500
+79% +$282K 0.03% 96
2022
Q4
$332K Buy
4,433
+700
+19% +$49.8K 0.02% 121
2022
Q3
$241K Buy
3,733
+300
+9% +$20.8K 0.01% 138
2022
Q2
$238K Hold
3,433
0.01% 139
2022
Q1
$264K Buy
+3,433
New +$247K 0.01% 144

Other funds holding HOLX

Perfromance Wealth Partners's HOLX Position: Q1 2025 in Review

Perfromance Wealth Partners sold out of Hologic (HOLX) in Q1 2025, closing a stake of 3,850 shares — an estimated $278K sold.

Perfromance Wealth Partners first reported a position in HOLX in Q1 2022 and held it in 12 quarters. The position peaked at $649K in Q2 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Perfromance Wealth Partners reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Perfromance Wealth Partners sold 3,850 Hologic shares in Q1 2025, an estimated $278K.
  • Perfromance Wealth Partners first reported a position in Hologic in Q1 2022 and held it in 12 quarters.
  • Perfromance Wealth Partners's Hologic position peaked at $649K in Q2 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Perfromance Wealth Partners's 13F filing for Q1 2025, filed 22 Apr 2025.